Cellectricon-preview

Cellectricon

Private

MölndalHealthcare & Life Scienceshttps://cellectricon.com/

Last Round

VC Round

Feb 21, 2008

Total Funding Raised

$11.87M

Momentum Score

25 /100

Company Overview

Cellectricon is a life sciences company that provides neuroscience drug discovery services intended to decipher disease mechanisms and identify and validate novel targets.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales

AI Layer

Non-AI

Keywords

contract research organizationCROneuroscience drug discoverydrug discovery servicesin-vitro researchneurobiology servicescell-based assaysphenotypic screeningoptical electrophysiologyhigh-content imagingneurotoxicity testingtarget discoverylead optimizationneurodegeneration researchresearch as a servicepharma outsourcingmicrofluidics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cellectricon Comps

Public and private peers based on sector, stage, and business model.

Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Cellectricon Funding Rounds

Historical fundraising activity

Round	Date	Amount Raised	Valuation	Investors	Sources
VC Round	Feb 21, 2008
Series B	May 26, 2004
Series A	Jul 11, 2002

View all Funding Rounds

Key People

Founding team and executive leadership

Mattias Karlsson

Chief Executive Officer, Chief Technology Officer

Executive Team

Lotta Agholme

Chief Operating Officer, Laboratory Operations Manager

Executive Team

Cellectricon Investors

Notable investors and investment history

Investor	Rounds
Investor Growth Capital	VC Round, Series A, Series B
Karolinska Development AB	Series A, Series B
Dunross & Co	VC Round
InnovationsKapital Nordic Advisors	Series B
InnovationsKapital	VC Round, Series A
Ägir Invest	VC Round

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Jan 21, 2026
Monthly visitors grew 47% MoM.
May 3, 2025
Monthly visitors increased 85% MoM, reaching 2.4K.

View all signals

Cellectricon Filings

SEC and related filings with document metadata.

Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Cellectricon Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Cellectricon's valuation, stock price, and market status.

Firmographic Details

HeadquartersMölndal

Employee Range24

Year Founded2003

Last FundingFeb 21, 2008

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.